11/20/2025
We are proud to be the first in the world to treat our cardiovascular patients with a new innovative valve repair system. The new approach treats those with mitral and tricuspid regurgitation, also known as leaky heart valves.
“We are excited to offer our patients this novel, minimally invasive approach to treating severe valvular regurgitation, a condition for which there are few safe and effective treatment options with this degree of efficiency,” said professor and director Gagan D. Singh, who performed the first procedure globally at UC Davis Medical Center.
Learn more about this breakthrough and how our team is leading the way in minimally invasive heart care: https://health.ucdavis.edu/news/headlines/uc-davis-health-performs-worlds-first-transcatheter-procedure-with-new-valve-repair-system/2025/11
Image Description: A group of health care professionals are standing together in a hospital procedure room. They are wearing colorful protective lead aprons, surgical scrubs and shoe covers. Several team members are holding a large blue banner labeled “Abbott MitraClip Delivery System XT W,” which features an illustration of the MitraClip device.